BBSRC Portfolio Analyser
BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments:
UKRI - What we have funded
Investigator / Supervisor details
Name
Dr Philip Kerry
Current Institution
AstraZeneca plc
Current Department
AstraZeneca Charnwood
Previous Institutions
Current Awards
No current BBSRC awards
Completed Awards
Reference
Title
Award Role
Value £
Type
00/A2/C/06131
Models to predict preclinical eye toxicity
Co-Supervisor
37,668
Studentships
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search